I am a
Home I AM A Search Login

Accepted

Share this

Dorsal raphe GABA-ergic neurons regulate the susceptibility to social transfer of pain in mice.

Some individuals are more susceptible to developing or suffering from pain states than others. However, the brain mechanisms underlying the susceptibility to pain responses are unknown. In this study, we […]

Learn More >

Suzetrigine: The first Nav1.8 inhibitor approved for the treatment of moderate to severe acute pain.

Opioids are commonly prescribed for the management of moderate to severe pain, but their use is associated with dependency and other adverse effects. For decades, the development of safe and […]

Learn More >

Equity Using Interventions for Pain and Depression (EQUIPD): A Pilot Randomized Trial.

Despite increased calls for improved health equity, Black patients continue to experience worse pain and associated outcomes. Black patients are also offered fewer pain treatment options than White patients and […]

Learn More >

Red nucleus mGluR4 and mGluR8 inhibit nociception and the development of neuropathic pain by restraining the expressions of TNF-α and IL-1β.

Metabotropic glutamate receptors (mGluR) participate in pain modulation and mediate different effects in nociceptive stimuli, relying on the receptor subtype activated and its anatomical location. Here, we addressed the functions […]

Learn More >

The properties of TREM1 and its emerging role in pain-related diseases.

The TREM1 receptor, a member of the TREMs family, is expressed by myeloid cells and functions as an initiator or enhancer of the inflammatory response, playing a pivotal role in […]

Learn More >

Advances in GLP-1 receptor agonists for pain treatment and their future potential.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) show substantial efficacy in regulating blood glucose levels and lipid metabolism, initially as an effective treatment for diabetes mellitus. In recent years, GLP-1RAs have become […]

Learn More >

Aspirin-responsive gene switch regulating therapeutic protein expression.

Current small-molecule-regulated synthetic gene switches face clinical limitations such as cytotoxicity, long-term side-effects and metabolic disturbances. Here, we describe an advanced synthetic platform inducible by risk-free input medication (ASPIRIN), which […]

Learn More >

Neuropathic pain management: a focused review of current treatments and novel data from main ongoing clinical trials.

Neuropathic pain (NP) remains a significant challenge in clinical practice, requiring a sophisticated pharmacotherapeutic strategy for effective symptom management. This review provides a comprehensive analysis of the current pharmacological treatments […]

Learn More >

Role of efferocytosis in chronic pain — From molecular perspective.

The complex nature of pain pathophysiology complicates the establishment of objective diagnostic criteria and targeted treatments. The heterogeneous manifestations of pain stemming from various primary diseases contribute to the complexity […]

Learn More >

Neural response associated with the modulation of temporal summation of second pain by affective touch.

Temporal summation of second pain (TSSP) is a phenomenon that has clinical relevance but insights into its functioning are limited. Lately, ‘affective touch’ (AT) has been shown to have pain […]

Learn More >

Search